Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter prospective comparison of desmopressin versus desmopressin + imidafenacin in nocturia with overactive bladder symptoms
KCT0003435Phase 4Completed
- Sponsor
- Chong Kun Dang
- Start
- Jan 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of desmopressin, imidafenacin in nocturia, overactive bladder (OAB), sponsored by Chong Kun Dang. Started Jan 2019; status: completed.
02
Drugs
desmopressinimidafenacin
03
Conditions
nocturiaoveractive bladder (OAB)
Beyond the preview
Go deeper on KCT0003435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003435.